TCMP
LLY icon

Thrive Capital Management (Pennsylvania)’s Eli Lilly LLY Stock Holding History

Thrive Capital Management (Pennsylvania)’s Portfolio LLY Stock Details LLY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$5.22M Buy
4,356
+445
+11% +$455K 0.98% 20
2026
Q1 		$3.6M Buy
3,911
+3,367
+619% +$3.41M 0.79% 61
2025
Q4 		$584K Buy
544
+47
+9% +$44.9K 0.13% 122
2025
Q3 		$380K Buy
497
+11
+2% +$8.19K 0.1% 142
2025
Q2 		$379K Buy
486
+151
+45% +$117K 0.12% 132
2025
Q1 		$277K Buy
+335
New +$279K 0.17% 100
2024
Q4 		– Sell
-504
Closed -$447K – 141
2024
Q3 		$447K Buy
504
+15
+3% +$13.5K 0.21% 131
2024
Q2 		$443K Buy
489
+3
+0.6% +$2.4K 0.2% 133
2024
Q1 		$378K Buy
486
+51
+12% +$36.3K 0.2% 69
2023
Q4 		$254K Buy
435
+1
+0.2% +$584 0.14% 116
2023
Q3 		$233K Buy
+434
New +$224K 0.13% 120

Other funds holding LLY

Lilly Endowment
Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $202B AUM 37.79% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Thrive Capital Management (Pennsylvania)'s LLY Position: Q2 2026 in Review

Thrive Capital Management (Pennsylvania) increased its Eli Lilly (LLY) stake by 11% in Q2 2026, buying an estimated $455K and bringing the position to 4,356 shares worth $5.22M. The position accounts for 0.98% of the portfolio, ranked #20.

Thrive Capital Management (Pennsylvania) first reported a position in LLY in Q3 2023 and has held it in 11 quarters since. 4,630 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Thrive Capital Management (Pennsylvania) held 4,356 shares of Eli Lilly worth $5.22M as of Q2 2026.
  • Thrive Capital Management (Pennsylvania) bought 445 Eli Lilly shares in Q2 2026, an estimated $455K.
  • Eli Lilly made up 0.98% of Thrive Capital Management (Pennsylvania)'s portfolio in Q2 2026, its #20 holding.
  • Thrive Capital Management (Pennsylvania) first reported a position in Eli Lilly in Q3 2023 and has held it in 11 quarters since.
  • 4,630 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Thrive Capital Management (Pennsylvania)'s 13F filing for Q2 2026, filed 5 Aug 2026.